Edition:
India

Bruker Corp (BRKR.OQ)

BRKR.OQ on NASDAQ Stock Exchange Global Select Market

46.17USD
3 Aug 2020
Change (% chg)

-- (--)
Prev Close
$46.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
316,365
52-wk High
$54.49
52-wk Low
$30.80

Latest Key Developments (Source: Significant Developments)

Bruker Corp Says Expects 2019 Organic Revenue Growth To Be At Or Near High End Of Co's Prior Organic Growth Guidance Range
Tuesday, 14 Jan 2020 

Jan 13 (Reuters) - Bruker Corp ::BRUKER CORP - EXPECTS 2019 ORGANIC REVENUE GROWTH TO BE AT OR NEAR HIGH END OF CO'S PRIOR ORGANIC GROWTH GUIDANCE RANGE.  Full Article

Bruker Announces Acquisition Of Magnettech's EPR Business
Wednesday, 2 Oct 2019 

Oct 2 (Reuters) - Bruker Corp ::BRUKER ANNOUNCES ACQUISITION OF MAGNETTECH'S EPR BUSINESS.BRUKER CORP - FINANCIAL DETAILS OF TRANSACTION WERE NOT DISCLOSED..  Full Article

Bruker Posts Q2 EPS Of $0.23
Friday, 2 Aug 2019 

Aug 1 (Reuters) - Bruker Corp ::BRUKER REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $0.33.Q2 GAAP EARNINGS PER SHARE $0.23.Q2 REVENUE $490.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $477.8 MILLION.SEES FY 2019 REVENUE UP 7 TO 8 PERCENT.Q2 EARNINGS PER SHARE ESTIMATE $0.30 -- REFINITIV IBES DATA.CONFIRMS FY 2019 REVENUE GROWTH, NON-GAAP OPERATING MARGIN EXPANSION AND EARNINGS OUTLOOK.FY2019 EARNINGS PER SHARE VIEW $1.62, REVENUE VIEW $2.04 BILLION -- REFINITIV IBES DATA.  Full Article

Bruker Comments On Block Trade Transaction
Wednesday, 17 Jul 2019 

July 17 (Reuters) - Bruker Corp ::BRUKER COMMENTS ON BLOCK TRADE TRANSACTION.BRUKER CORP - JOERG LAUKIEN RETIRED FROM BRUKER BOARD OF DIRECTORS EFFECTIVE NOVEMBER 5, 2018.BRUKER CORP - ADVISED THAT FORMER BOARD MEMBER, MR. JOERG C. LAUKIEN, HAS AUTHORIZED A BLOCK SALE OF BRUKER SHARES AS PART OF HIS RETIREMENT PLANNING.BRUKER CORP - JOERG LAUKIEN IS BROTHER OF CEO WHO IS NOT SELLING ANY SHARES IN THIS TRANSACTION..  Full Article

Bruker And Champalimaud Foundation Collaborate To Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications
Monday, 13 May 2019 

May 13 (Reuters) - Bruker Corp ::BRUKER AND CHAMPALIMAUD FOUNDATION ANNOUNCE COLLABORATION TO DEVELOP NOVEL ULTRA-HIGH FIELD 18 TESLA PRECLINICAL MRI SYSTEM AND APPLICATIONS.BRUKER CORP - 18T MRI IS EXPECTED TO BE INSTALLED IN LATE 2021 IN NEUROPLASTICITY AND NEURAL ACTIVITY LABORATORY.  Full Article

Bruker Q4 GAAP Earnings Per Share $0.50
Tuesday, 12 Feb 2019 

Feb 11 (Reuters) - Bruker Corp ::BRUKER REPORTS FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.54.Q4 GAAP EARNINGS PER SHARE $0.50.Q4 REVENUE $553.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $544.6 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.54 -- REFINITIV IBES DATA.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $1.54 TO $1.58.SEES FY 2019 REVENUE UP 6 TO 7 PERCENT.FOR FY 2019, SEES ORGANIC REVENUE GROWTH OF 4% TO 5%.SEES NEGATIVE FOREIGN CURRENCY TRANSLATION EFFECT ON REVENUE OF 2% IN 2019.EXPECTS AN INCREASE IN FY 2019 NON-GAAP OPERATING MARGIN OF 70 BPS TO 100 BPS YEAR-OVER-YEAR FROM 16.8% IN FY 2018.FY2019 REVENUE VIEW $1.97 BILLION -- REFINITIV IBES DATA.  Full Article

Bruker Announces Agreement To Acquire Majority In Hain Lifescience GmbH
Friday, 24 Aug 2018 

Aug 24 (Reuters) - Bruker Corp ::BRUKER ANNOUNCES AGREEMENT TO ACQUIRE MAJORITY IN INFECTIOUS DISEASE-FOCUSED MOLECULAR DIAGNOSTICS (MDX) COMPANY HAIN LIFESCIENCE GMBH.EXPECTS TO ACQUIRE AN 80% MAJORITY INTEREST IN HAIN, WITH OPTIONS FOR REMAINING 20% THAT CAN BE EXERCISED AFTER 2021.IN 2018 HAIN EXPECTS TO GENERATE REVENUES OF ABOUT $38 MILLION.FINANCIAL DETAILS OF THE DEAL WERE NOT DISCLOSED.EXPECTS HAIN TO CONTINUE DOING BUSINESS AS 'BRUKER-HAIN DIAGNOSTICS'.BRUKER INTENDS TO RETAIN ESSENTIALLY ALL HAIN EMPLOYEES AND HAIN RESEARCH AND DEVELOPMENT, MANUFACTURING AND DISTRIBUTION CAPABILITIES.IN 2019, BRUKER ANTICIPATES TRANSACTION TO BE ACCRETIVE TO BRUKER'S NON-GAAP EPS BY $0.01-$0.02.DOES NOT EXPECT DEAL TO HAVE ANY MATERIAL IMPACT ON BRUKER'S 2018 NON-GAAP OPERATING MARGIN EXPANSION AND EPS GUIDANCE.  Full Article

BRIEF-Bruker Introduces Breakthrough Maldi-2 Source On Timstof Flex, And Further Innovations In CCS-Enabled 4D Proteomics On Timstof

* BRUKER INTRODUCES BREAKTHROUGH MALDI-2 SOURCE ON TIMSTOF FLEX, AND FURTHER INNOVATIONS IN CCS-ENABLED 4D PROTEOMICS ON TIMSTOF Source text for Eikon: Further company coverage: